A little weed may change gray matter volume in the teenage brain. (Journal of Neuroscience)
Pediatric epilepsy smartband is approved for detecting signs of generalized tonic-clonic seizures, device maker Empatica announced.
Clinical subtyping of Parkinson’s disease is feasible at diagnosis and provides an accurate estimation of disease progression and survival. (JAMA Neurology)
EEGs show the human brain works backward to reconstruct memories. (Nature Communications)
Scientific American explores the neuroscience of creativity.
Undiagnosed temporal lobe seizures caused a man’s cyclical pattern of heavy sweating episodes. (Annals of Internal Medicine)
Gout was linked to an elevated risk of Parkinson’s disease in the U.S. (BMC Neurology)
Rituximab (Rituxan) induction followed by glatiramer acetate (Copaxone) appeared superior to glatiramer acetate alone in relapsing multiple sclerosis, but the effect was not sustained. (Neurology)
Britain’s health cost watchdog NICE nixed CGRP receptor inhibitor erenumab (Aimovig), noting there was no evidence suggesting it was more effective than botulinum toxin type A (Botox) for chronic migraine. (Endpoints News)
But can Botox for migraine hang with the CGRP drugs? Some analysts are skeptical. (FiercePharma)